Breast Cancer Recurrences

Last Modified: April 11, 2008

Question

Dear OncoLink "Ask The Experts,"

My oncologist once mentioned that roughly 75% of breast cancer recurrences are metastatic. If this is true, most patients who recur would eventually die after a recurrence. I can't find any substantiation for his remark. Can you tell me whether he is right or not? I am trying to decide whether or not to continue an aromatase inhibitor.

Answer

Kevin R. Fox, MD, Assistant Director, Clinical Affairs and Associate Professor of Hematology/Oncology at the Abramson Cancer Center of the University of Pennsylvania, responds:

Unfortunately, it IS true...of all breast cancer recurrences, 75% or so are metastatic, and about 25% are "local"-only recurrences, meaning they care confined to just the breast region. Metastatic breast cancer carries a median life expectancy of about 2.5 to 3 years. If a patient is taking an aromatase inhibitor to prevent recurrence, I would recommend that she continue.

Blogs

The Best of the Breast
by OncoLink Editorial Team
October 03, 2014

Is Ayurveda the Answer to Women’s Health Issues?
by The 4Wholeness Team
September 01, 2015